| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Mersana Therapeutics, Inc.: Mersana Therapeutics to Present at Upcoming Investor Conferences | 3 | GlobeNewswire (USA) | ||
| 09.05. | Earnings call: Mersana Therapeutics outlines clinical progress | 6 | Investing.com | ||
| 09.05. | Mersana Therapeutics, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 09.05. | Mersana Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 03.05. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 128 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
| 02.05. | Mersana Therapeutics, Inc.: Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024 | 1 | GlobeNewswire (USA) | ||
| 04.04. | Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 99 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug... ► Artikel lesen | |
| 19.03. | The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts | 12 | Benzinga.com | ||
| 29.02. | Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts | 17 | Benzinga.com | ||
| 28.02. | Mersana Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 28.02. | Mersana Therapeutics, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 28.02. | Mersana Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 28.02. | Mersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results | 320 | GlobeNewswire (Europe) | Enrollment in dose escalation and backfill cohorts continuing in Phase 1 clinical trial of XMT-1660; expect to initiate tumor-specific expansion cohorts in the second quarter of 2024 and announce... ► Artikel lesen | |
| 27.02. | A Preview Of Mersana Therapeutics' Earnings | 5 | Benzinga.com | ||
| 27.02. | Mersana Therapeutics Q4 2023 Earnings Preview | 3 | Seeking Alpha | ||
| 27.02. | Mersana Therapeutics, Inc.: Mersana Therapeutics to Present at Upcoming Investor Conferences | 3 | GlobeNewswire (USA) | ||
| 21.02. | Mersana Therapeutics, Inc.: Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024 | 11 | GlobeNewswire (USA) | ||
| 01.02. | Mersana Therapeutics, Inc.: Mersana Therapeutics to Participate in Guggenheim's 6th Annual Biotechnology Conference | 8 | GlobeNewswire (USA) | ||
| 12.01. | Mersana Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 6 | SEC Filings | ||
| 05.01. | Mersana Therapeutics, Inc. - 8-K, Current Report | 6 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 434 |
| EVOTEC | 294 |
| NEL | 266 |
| TUI | 241 |
| GAMESTOP | 200 |
| BIONTECH | 177 |
| BAYER | 175 |
| PLUG POWER | 157 |
| DEUTSCHE LUFTHANSA | 133 |
| RHEINMETALL | 120 |
| VOLKSWAGEN | 101 |
| BYD | 100 |
| DEUTSCHE BANK | 98 |
| TESLA | 97 |
| SIEMENS ENERGY | 95 |
| SUPER MICRO COMPUTER | 94 |
| COMMERZBANK | 80 |
| PAYPAL | 80 |
| AMD | 77 |
| RWE | 77 |
| BASF | 76 |
| THYSSENKRUPP | 76 |
| MICROSOFT | 73 |
| MERCEDES-BENZ | 70 |
| AIXTRON SE | 68 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
